Tag:
CE Mark
Latest Headlines
Latest Headlines
Mitralign grabs $35M Series D cash to advance mitral valve repair device
Cardiac device company Mitralign attracted $35 million in new Series D financing. The Tewksbury, MA, company plans to use the investment infusion with its eyes toward European testing and commercial launch for its catheter-based mitral valve repair system.
Abiomed snags CE mark for Impella cVAD heart pump
Abiomed ($ABMD) is gearing up for a full European commercial launch of its Impella cVAD heart pump by this summer, now that it has obtained a CE mark for the device.
Medtronic scores CE Mark for MRI-friendly pacemaker lead
Medtronic ( $MDT ) has launched its CapSure Sense MRI SureScan pacing leads internationally after securing CE Mark approval. The leads are approved for use during MRI procedures. And this is very good news, as MRI procedures are indicated for 17% of pacemaker patients within 12 months of device implant, according to a company statement.
Koning gets CE Mark for breast CT system
West Henrietta, NY-based Koning has obtained CE Mark approval for its breast CT system. The system is the first commercially available, fully integrated breast CT scanner designed specifically to...
BD gets CE Mark for MRSA assay
On Thanksgiving Day, BD Diagnostics announced it had received CE Mark approval for the BD MAX MRSA assay, which is designed to rapidly and accurately identify methicillin-resistant Staphylococcus
Neovasc gets CE Mark for Reducer
Vancouver-based Neovasc ($NVC) has received CE Mark designation for its Reducer product for the treatment of refractory angina. The Reducer can be implanted quickly in a minimally invasive procedure
